Company Analysis
Sign in

Genenta Science S.p.A. (GNTA)

Nasdaq: GNTA · Biological Products, (No Diagnostic Substances) · Milan, IT · filing with the SEC since 2021
Full chart Alerts Compare
Grade5.4
◀ Past 6.7● Present 5.6▶ Future 4.3
7 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Income statement, as filed

In euros (EUR), as filed; per-share figures in euros; share counts.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019
Report filedApr 1, 2026Mar 28, 2025Mar 29, 2024Apr 21, 2023May 2, 2022··
Research and development2,699,3424,812,8546,474,4415,338,9623,390,6774,688,4613,702,982
General and administrative3,904,3984,951,4565,258,5015,705,0302,296,596901,765921,520
Total operating expenses6,603,7409,764,31011,732,94211,043,9925,687,2735,590,2264,624,502
Operating income-6,603,740-9,764,310-11,732,942-11,043,992-5,687,273-5,590,226-4,624,502
Other income (expense), net11,456529,683-4,875242,55419,6575,96636,331
Total non-operating income (expense)73,913851,81587,4872,566,229157,941-1,78826,779
Income before income taxes-6,529,827-8,912,495-11,645,455-8,477,763-5,529,332-5,592,014-4,597,723
Net income-6,529,827-8,912,495-11,645,455-8,477,763-5,529,332-5,592,014-4,597,723
Earnings per share, basic··-0.64-0.47-0.37··
Earnings per share, diluted-0.33-0.49-0.64-0.47-0.37··
Weighted average shares, basic19,710,18718,273,49018,216,90718,216,85815,083,825··
Weighted average shares, diluted19,710,18718,273,49018,216,90718,216,85815,083,825··
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense
General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense
Total operating expenses the running costs togetherus-gaap:OperatingExpenses
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense
Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
SI Assistanton GNTA · research, not advice